Did you know that breast cancer is currently the most diagnosed cancer in women in the US? It is also the second leading cause of cancer death in American women. Luckily, there is some good news. According to the American Cancer Society, breast cancer deaths are declining, thanks to proactivity in screening, early detection, and high-quality treatment. Breast cancer risk assessment can play a large role in a successful breast screening program.
If you run a breast care facility, you can grow your high-risk screening program with MagView. You can rely on our risk assessment software to streamline patient data collection, analysis, communication, and workflow management.
Breast cancer risk assessment is essential for identifying women who can benefit from more intensive breast cancer surveillance. Our comprehensive breast cancer risk assessment software allows you to identify, communicate with, and closely follow high-risk patients. The tool helps you provide personalized care for all your patients.
Patients can complete their health history online from anywhere, saving time for both parties. MagView can calculate the risk assessment score and flag high-risk patients immediately. We also integrate the score into your radiologists’ reporting without interrupting your workflow or the patient’s.
The patient's risk score informs decisions about supplemental screening in addition to mammography, such as breast MRI and/or referral for genetic counseling. These downstream services can increase revenue and lead to better patient outcomes.
A comprehensive risk assessment program incorporates genetic risk. We integrate with genetic testing labs, to ensure that the appropriate patients receive the genetic education and testing they need, in a timely manner, and without a burden on your screening workflow.
Precision screening is increasingly becoming the popular approach to breast cancer screening with the aim of strict follow-up in high-risk women. The ACR, SBI, NAPBC, NCCN, ACOG and ASBrS all champion the importance of breast cancer risk assessment.
Risk models within MagView leverage a women’s personal and family history to accurately categorize her breast cancer risk, paving the way for more personalized and effective screening.
Certain risk assessment models check factors such as BRCA1 or BRCA2 inherited gene mutation linked to a high risk of breast cancer. Other key risk factors include:
The more positive answers given, the more likely a person is at high risk of breast cancer. The risk models built into MagView assess the likelihood of developing breast cancer over the next five years and up to a lifetime.
MagView allows you to use several risk assessment models to assess your patients. The Tyrer-Cuzick v8.0 (IBIS) is one of the most reliable breast cancer risk assessment tools you can use for a professional assessment. The tool checks various family factors, reproductive history, and overall medical history to estimate a patient’s breast cancer risk. Other risk models include NCI, Claus, NCCN, BCSC, HERA, and many more.
Need a robust risk program for breast cancer screening? MagView has a solid solution for you. Our breast cancer risk assessment software allows you to receive patients’ assessment scores, communicate with your patient, follow up and manage the entire screening process smoothly.
Contact us to learn more about how we can support your high-risk breast screening program.
UPCOMING WEBINAR: Navigating New Regulations in 2024: A Guide to Compliance for MQSA, NAPBC, and MOD
